Article info

Original research
Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

Authors

  1. Correspondence to Dr Yukihiro Umeda; umeda{at}u-fukui.ac.jp
View Full Text

Citation

Sato M, Umeda Y, Tsujikawa T, et al
Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

Publication history

  • Accepted June 28, 2021
  • First published July 22, 2021.
Online issue publication 
July 22, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.